Requirements for Procedures Related to the Collection, Processing, Storage and Issue of HUMAN Haemopoietic Progenitor Cells (Third Edition 2009)
Acronyms and abbreviations
- Scope
- Acronyms and abbreviations
- Definitions
- Introduction
1. Quality management- 2. Donor evaluation and selection
- 3. Cellular therapy product collection
- 4. Product processing
- 5. Cellular therapy product testing
- 6. Labelling
- 7. Cellular therapy storage areas
- 8. Cellular product issue and distraction
- 9. Transport and disposal
- 10. Adverse events
- 11. Health and safety
- Bibliography
- Additional reading
- Appendices
- Appendix A (Part I - Normative, Part II - Informative)
- Appendix B (Normative and Informative)
- Appendix C (Informative)
- Appendix D (Informative)
- Appendix E (Normative)
ABMDR Australian Bone Marrow Donor Registry
ABO human erythrocyte A, B, O antigens
ASEATTA Australasian and South East Asian Tissue Typing Association
ASHI American Society of Histocompatibility and Immunogenetics
CMV cytomegalovirus
FACT Foundation for the Accreditation of Cellular Therapy
HLA human leukocyte antigen
HPC haemopoietic progenitor cell
HPC–A haemopoietic progenitor cells–apheresis (other acceptable term: HPC,A)
HPC–M haemopoietic progenitor cells–marrow (other acceptable term: HPC,M)
ISBT International Society of Blood Transfusion
NATA National Association of Testing Authorities, Australia
NPAAC National Pathology Accreditation Advisory Council
RCPARoyal College of Pathologists of Australasia
Rh human erythrocyte rhesus antigens
TGA Therapeutic Goods Administration
